The Efficacy and Safety of Abelmoschus manihot for Reduction of Microalbuminuria in Patients with Type 2 Diabetes and Diabetic Nephropathy-A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Trial

被引:0
|
作者
Yin, Jun
Chen, Si
Wei, Li
Jia, Weiping
机构
基金
中国国家自然科学基金;
关键词
D O I
10.2337/db23-11-LB
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
11-LB
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial
    Li, Ping
    Lin, Hongli
    Ni, Zhaohui
    Zhan, Yongli
    He, Yani
    Yang, Hongtao
    Fang, Jingai
    Wang, Niansong
    Li, Wenge
    Cai, Guangyan
    Chen, Yizhi
    Zhang, Peiqing
    Wang, Xiaoqin
    Chen, Qinkai
    Li, Zhenjiang
    Sun, Xuefeng
    Chen, Xiangmei
    PHYTOMEDICINE, 2020, 76
  • [2] Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial
    Zhao, Jing
    Tostivint, Isabelle
    Xu, Lingdong
    Huang, Jihan
    Gambotti, Laetitia
    Boffa, Jean-Jacques
    Yang, Min
    Wang, Ling
    Sun, Zhuxing
    Chen, Xiaolan
    Liou-Schischmanoff, Amelie
    Baumelou, Alain
    Ma, Teng
    Lu, Guoyuan
    Li, Ling
    Chen, Dai
    Pieroni, Laurence
    Liu, Bingkai
    Qin, Xiao
    He, Weiming
    Wang, Yuejuan
    Gu, Harvest F.
    Sun, Wei
    DIABETES CARE, 2022, 45 (07) : E113 - E115
  • [3] Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial
    Li Ni
    Zheng Wen
    Xiaowen Hu
    Wei Tang
    Haisheng Wang
    Ling Zhou
    Lujin Wu
    Hong Wang
    Chang Xu
    Xizhen Xu
    Zhichao Xiao
    Zongzhe Li
    Chene Li
    Yujian Liu
    Jialin Duan
    Chen Chen
    Dan Li
    Runhua Zhang
    Jinliang Li
    Yongxiang Yi
    Wei Huang
    Yanyan Chen
    Jianping Zhao
    Jianping Zuo
    Jianping Weng
    Hualiang Jiang
    Dao Wen Wang
    Frontiers of Medicine, 2021, 15 : 704 - 717
  • [4] Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial
    Ni, Li
    Wen, Zheng
    Hu, Xiaowen
    Tang, Wei
    Wang, Haisheng
    Zhou, Ling
    Wu, Lujin
    Wang, Hong
    Xu, Chang
    Xu, Xizhen
    Xiao, Zhichao
    Li, Zongzhe
    Li, Chene
    Liu, Yujian
    Duan, Jialin
    Chen, Chen
    Li, Dan
    Zhang, Runhua
    Li, Jinliang
    Yi, Yongxiang
    Huang, Wei
    Chen, Yanyan
    Zhao, Jianping
    Zuo, Jianping
    Weng, Jianping
    Jiang, Hualiang
    Wang, Dao Wen
    FRONTIERS OF MEDICINE, 2021, 15 (05) : 704 - 717
  • [5] Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled,multicenter clinical trial
    Li Ni
    Zheng Wen
    Xiaowen Hu
    Wei Tang
    Haisheng Wang
    Ling Zhou
    Lujin Wu
    Hong Wang
    Chang Xu
    Xizhen Xu
    Zhichao Xiao
    Zongzhe Li
    Chene Li
    Yujian Liu
    Jialin Duan
    Chen Chen
    Dan Li
    Runhua Zhang
    Jinliang Li
    Yongxiang Yi
    Wei Huang
    Yanyan Chen
    Jianping Zhao
    Jianping Zuo
    Jianping Weng
    Hualiang Jiang
    Dao Wen Wang
    Frontiers of Medicine, 2021, 15 (05) : 704 - 717
  • [6] Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial
    Zhang, Li
    Li, Ping
    Xing, Chang-ying
    Zhao, Jiu-yang
    He, Ya-ni
    Wang, Jian-qin
    Wu, Xiong-fei
    Liu, Zhang-suo
    Zhang, Ai-ping
    Lin, Hong-li
    Ding, Xiao-qiang
    Yin, Ai-ping
    Yuan, Fa-huan
    Fu, Ping
    Hao, Li
    Miao, Li-ning
    Xie, Ru-juan
    Wang, Rong
    Zhou, Chun-hua
    Guan, Guang-ju
    Hu, Zhao
    Lin, Shan
    Chang, Ming
    Zhang, Miao
    He, Li-qun
    Mei, Chang-lin
    Wang, Li
    Chen, Xiangmei
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 64 (01) : 57 - 65
  • [7] Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria A Randomized, Controlled Trial
    Ito, Sadayoshi
    Kagawa, Tomoya
    Saiki, Takuya
    Shimizu, Kohei
    Kuroda, Shingo
    Sano, Yuhei
    Umeda, Yuusuke
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (03): : 354 - 363
  • [8] Insulin VLAject™ and regular human insulin in patients with type 2 diabetes:: Efficacy and safety in an open-label multicenter clinical trial
    Steiner, S.
    Pfuetzner, A.
    Sethi, B.
    Forst, T.
    Klonoff, D.
    Simms, P.
    Pohl, R.
    Flacke, F.
    DIABETOLOGIA, 2008, 51 : S273 - S273
  • [9] Multifactorial Intervention on Type 2 Diabetes (MIDiab) Study: A multicenter,open-label, randomized, parallel controlled, community trial
    Wang, Yupeng
    Guan, Qingbo
    Hou, Xu
    Zhang, Xu
    Zhang, Haiqing
    Xu, Chao
    Jing, Fei
    Ma, Shizhan
    Shao, Shanshan
    Zhao, Meng
    Guo, Qingling
    Zhong, Fang
    Gao, Ling
    Zhao, Jiajun
    JOURNAL OF DIABETES, 2020, 12 (11) : 862 - 864
  • [10] Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
    Kim, Jeong Mi
    Kim, Sang Soo
    Kim, Jong Ho
    Kim, Mi Kyung
    Kim, Tae Nyun
    Lee, Soon Hee
    Lee, Chang Won
    Park, Ja Young
    Kim, Eun Sook
    Lee, Kwang Jae
    Choi, Young Sik
    Kim, Duk Kyu
    Kim, In Joo
    DIABETES & METABOLISM JOURNAL, 2020, 44 (01) : 67 - 77